Tutorials › Statistical Methods for Single-Cell RNA Sequencing › From Cell Capture to Gene Counts

Single-Cell Technologies and Count Data · Tutorial 1 of 700

From Cell Capture to Gene Counts

Trace how cellular RNA becomes sequence data and a gene-level count, while distinguishing the biological molecules from the reads produced by the assay.

Beginner 10 min read

What You'll Learn

  • Trace the main measurement stages from a captured cell to sequenced fragments.
  • Distinguish cells, RNA molecules, library molecules, and sequencing reads.
  • Explain why read depth does not directly equal the number of original RNA molecules.
  • Identify how assay design affects the meaning of a gene-level count.
  • Recognize common points where losses, amplification, or assignment choices affect counts.

From a Cell to a Number

A gene-by-cell count is not a direct census of every RNA molecule inside a cell. It is the endpoint of a measurement chain: a cell is selected, some of its RNA is made available, a library is prepared, fragments are sequenced, and sequence data are summarized as counts. Each step can change which molecules are represented and how often they appear in the data.

Understanding that chain starts with keeping three quantities separate. A cell is the biological unit being measured. An RNA molecule is a physical transcript present in or derived from that cell. A sequencing read is a recorded sequence from a library fragment. One cell can contain many RNA molecules, and one original RNA molecule can contribute zero, one, or multiple sequencing reads, depending on the assay and sampling process.

Definition: A gene-level count is a number assigned to a gene after sequence data have been processed and summarized under a particular assay and counting rule. Its unit is determined by that rule: it may represent assigned reads or, in assays designed to estimate original molecules, an estimate based on molecule-level evidence. The word “count” alone does not identify which unit is meant.

The Measurement Chain

The details vary across technologies, but the broad stages are similar. First, cells are collected or otherwise selected for measurement. The assay then makes RNA available for library preparation. In many protocols, RNA is converted into complementary DNA (cDNA), and prepared material is amplified or otherwise made suitable for sequencing. A sequencer records reads from sampled library fragments. Computational processing then associates usable sequence information with genes and summarizes the evidence according to the assay’s counting rule.

These stages do not preserve all biological material perfectly. Some cells may be lost or damaged. RNA may degrade, fail to be converted, or be lost during handling. Library preparation can represent some molecules more readily than others, and sequencing samples only part of the prepared library. Finally, a read may not provide enough reliable information for assignment to a gene. A zero in a processed result therefore need not mean that the cell contained no RNA from that gene.

1
Cell selection and handling.
A cell is included in the assay and its cellular material is retained for measurement. The assay’s intended cell unit is not itself a read or an RNA molecule.
2
RNA availability and library preparation.
RNA is released or otherwise made accessible, converted or prepared into sequenceable material, and may be amplified. The resulting library is a prepared representation of RNA, not a guaranteed one-to-one inventory of it.
3
Sequencing.
The instrument samples library fragments and records reads. Repeated reads can come from the same original molecule, while other molecules may not be sampled at all.
4
Gene-level summarization.
Processing determines which reads provide usable evidence for a gene and applies the assay’s counting rule. The resulting number is a measurement derived from the data, not a direct observation of every transcript in the cell.

Why the Three Units Are Not Interchangeable

The cell is the unit that connects measurements to a biological sample. The RNA molecule is the biological material whose abundance is of interest. The read is an instrument output. Library preparation and sequencing intervene between molecules and reads, so the read total generally depends on more than how many RNA molecules were originally present.

For example, amplification can produce multiple library fragments from material associated with an original molecule. Sequencing may then sample several of those fragments, or none of them. In other cases, library preparation may fail to represent the molecule. Consequently, a large read count can reflect abundant original RNA, effective library representation, repeated sampling, or a combination of these. A small read count can reflect low abundance, poor representation, limited sequencing, or assignment losses.

Key distinction: A read is evidence sampled from a prepared library; it is not automatically one original RNA molecule. A gene-level count has a clear interpretation only when the assay and the rule used to construct that count are known.

Worked Examples: Following the Measurement

Worked Example: Reads Are Not a Direct Molecule Census

Suppose, for illustration, that a hypothetical cell contains 12 RNA molecules from a particular gene. Library preparation represents 9 of them, and sequencing produces 3 reads associated with each of 4 represented molecules. How many original molecules, represented molecules, and reads are involved?

The original amount is given as 12 RNA molecules. Of these, 9 molecules are represented in the prepared library. The reads are \(3 \times 4 = 12\) reads, because four represented molecules each contribute three reads in this simplified example.

Thus there are 12 original molecules, 9 represented molecules, and 12 reads. The read total happens to equal the original molecule total, but that equality is coincidental: three original molecules were not represented, while repeated reads were produced from others. The read count alone cannot recover the original number in this example.

Worked Example: A Simplified Sampling Calculation

Consider a deliberately simplified model for one gene. Suppose a cell has \(M=20\) RNA molecules, each has an independent probability \(q=0.60\) of being represented in the library, and each represented molecule generates an average of \(r=2.5\) sequenced reads. What is the expected read total under this model?

The expected number of represented molecules is \(Mq = 20 \times 0.60 = 12\). Given the stated average of 2.5 reads per represented molecule, the expected read total is

$$ E[R] = Mqr = 20 \times 0.60 \times 2.5 = 30 \text{ reads}. $$

So the model gives an expected total of 30 reads. This is not a prediction that every such cell will yield exactly 30 reads, nor does it make 30 reads equivalent to 30 original molecules. The calculation relies on the assumed representation probability, average read contribution, and simplified independence structure. Real assays can have gene- and molecule-dependent efficiencies, and sequencing allocation is constrained by the library and run.

Worked Example: Interpreting Two Reported Counts

Two hypothetical cells have the following processed values for gene G. In a read-based assay, Cell A has 8 assigned reads. In an assay that uses molecule-level evidence, Cell B has a count of 8 estimated molecules. What can be concluded from the shared number?

The numerical values are both 8, but their stated units differ. Cell A has 8 assigned reads, meaning eight sequenced reads met that assay’s gene-assignment and counting rule. Cell B has 8 estimated molecules, meaning the assay’s molecule-level procedure supports an estimate of eight original RNA molecules for that gene.

It is not justified to conclude that both cells contained exactly eight original molecules, or that the gene had equal abundance in the two cells. Read-based counts can include repeated sampling of library material, while molecule-based estimates depend on their own measurement and correction rules. Comparing the values requires knowing the assay, the count unit, and the processing definition.

A Simple Justification for the Read–Molecule Gap

The simplified calculation above can be stated as a short derivation. Let \(M\) be the number of original RNA molecules for a gene. For each molecule \(i\), define \(C_i=1\) if it is represented in the library and \(C_i=0\) otherwise. Assume, for this illustration only, that \(P(C_i=1)=q\). Let \(Y_i\) be the number of reads arising from molecule \(i\) if represented, with mean \(E[Y_i]=r\). The total read count is \(R=\sum_{i=1}^{M} C_iY_i\), where an unrepresented molecule contributes zero.

By linearity of expectation, and under the stated assumption that the average read contribution for a represented molecule is \(r\),

$$ E[R] = \sum_{i=1}^{M} E[C_iY_i] = \sum_{i=1}^{M} q r = Mqr. $$

This result explains why read totals depend on both the number of original molecules and the measurement process. It is a conceptual model, not a universal count-conversion formula. In actual data, the probabilities and read contributions may vary across molecules, and a gene-level count may be defined using more than the number of assigned reads.

Assumptions, Diagnostics, and Failure Modes

Any interpretation should begin by establishing what the count represents. A useful description identifies the assay, the biological unit, and whether the reported number is a read count or another measurement unit. It should also state that counts are based on successfully processed and assigned evidence; they do not automatically include molecules lost or left unassigned along the way.

The simplified derivation assumes a fixed number \(M\), a common representation probability \(q\), and a common mean read contribution \(r\). These assumptions make the relationship transparent but may not fit real assays. Genes can differ in how efficiently their RNA is converted and represented. Molecules from the same gene can also be sampled unevenly, and finite sequencing depth can leave library fragments unobserved. For these reasons, the equation \(E[R]=Mqr\) should not be used to convert a real read count into an exact molecule count without a justified measurement model.

Several observations can alert an analyst to a mismatch between the data and a simple interpretation. Many zeros can occur even when molecules were present, because capture, preparation, sampling, or assignment may fail. Large differences in read totals between cells may reflect differing sequencing effort or library representation as well as biological differences. A gene’s reads may also be difficult to assign uniquely under the chosen processing rule. These are reasons to inspect the measurement and processing context; they do not, by themselves, identify the cause of a particular count pattern.

The main alternative measurement conventions answer related but different questions. A read-counting rule records sequence reads assigned to a gene. A molecule-oriented rule aims to estimate original molecules and can reduce the effect of repeated reads from amplified material, but it remains an estimate subject to capture and processing losses. Neither convention makes the underlying physical RNA fully observable. The appropriate interpretation depends on the assay and the scientific question; numeric values from different conventions should not be treated as directly interchangeable.

Common Mistakes and the Practical Meaning of a Count

  • Equating one read with one RNA molecule. A read comes from a prepared library fragment; amplification and sampling can break a one-to-one relationship.
  • Reading zero as biological absence. A zero means no evidence was recorded under the applied procedure, not necessarily that the cell contained no molecules of that gene.
  • Comparing counts without checking units. Eight assigned reads and eight estimated molecules are both numbers, but they do not have the same measurement meaning.
  • Treating the library as a complete copy of the cell’s RNA. Preparation can lose or unevenly represent material, and sequencing samples only part of the library.

The measurement chain matters because downstream statistical conclusions use the counts as data. Recognizing what was measured helps prevent biological claims from being stronger than the evidence allows. It also gives a principled starting point for later work on how sequence information is assigned, how different assays define counts, and how counts are organized for analysis.

Check Your Understanding

Answer each question by distinguishing the biological quantity from the recorded quantity.

  1. A hypothetical cell contains 15 RNA molecules from a gene. Five are represented in the library, and each of those yields two reads. How many original molecules, represented molecules, and reads are specified?
  2. In the simplified model, let \(M=10\), \(q=0.50\), and \(r=4\). Calculate the expected read total and state its unit.
  3. Why does a processed count of zero not establish that a cell contained no RNA molecules from that gene?
  4. Can a count of 12 assigned reads be interpreted as 12 original molecules without additional information? Explain.

Solutions. (1) There are 15 original molecules, 5 represented molecules, and \(5 \times 2=10\) reads. (2) \(E[R]=Mqr=10 \times 0.50 \times 4=20\) reads. This is an expected read total under the stated simplified assumptions. (3) A molecule may fail to be represented, sampled, or assigned, so a zero records no qualifying evidence rather than proving biological absence. (4) No. The 12 reads are sequence observations under a read-counting rule; repeated reads and unobserved molecules can separate that total from the number of original molecules.

Clinical Biostats